Photo of Ronald E. Creamer Jr.

Ronald E. Creamer Jr.

Partner, Cravath

212-474-1010rcreamer@cravath.com

Two Manhattan West
375 Ninth Avenue
New York, NY 10001

View Firm Biography

Ron Creamer is a seasoned tax practitioner in all types of acquisitions and dispositions, particularly cross-border transactions. Creamer is noted for his calm, business-oriented approach and his ability to achieve consensus in complex negotiations. In addition to advising on the tax aspects of M&A transactions, Creamer regularly counsels clients on the execution and IRS review of tax-efficient financing techniques and capital markets strategies.

Notable transactions include representing:

  • Kenvue in its pending $48.7 billion acquisition by Kimberly‑Clark;
  • Banco Sabadell in its defense against the €17 billion unsolicited takeover bid from BBVA;
  • UScellular’s independent directors in the $4.4 billion sale of UScellular’s wireless operations and select spectrum assets to T‑Mobile;
  • Deutsche Börse in its €3.9 billion acquisition of SimCorp and the combination of ISS and Qontigo’s index business as ISS STOXX;
  • Credit Suisse in its CHF3.475 billion merger into UBS;
  • Jefferies in the significant expansion of its Global Strategic Alliance with SMBC Group—which includes a joint venture combining their Japanese equities and ECM businesses, and an increase in SMBC’s equity ownership in Jefferies to up to 20%—and in the previous expansion that included a total commitment of up to $3.4 billion to Jefferies by SMBC;
  • Texas Capital Bank in the $3.4 billion sale of BankDirect to Truist;
  • WiseTech Global in its $2.1 billion acquisition of e2open, its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
  • ADT in the $1.6 billion sale of its commercial business to GTCR and its $1.2 billion equity investment from State Farm;
  • Dowlais in its pending £1.16 billion combination with American Axle & Manufacturing; 
  • Convey Health Solutions in its $1.1 billion take-private acquisition by TPG Capital;
  • Lifezone Metals in its approximately $1 billion SPAC combination with GoGreen Investments;
  • Hasbro in the $500 million sale of its eOne Film and TV Business to Lionsgate;
  • Ahold Delhaize in the sale of its FreshDirect business to Getir;
  • Airspan in the sale of Mimosa to Radisys;
  • entrotech in the formation of PPG Advanced Surface Technologies, a joint venture with PPG Industries;
  • Illumina in its spin-off of GRAIL and its pending acquisition of SomaLogic;
  • OMERS Private Equity in its acquisition of Integris and its acquisition of a majority stake in Knight Commercial;
  • Owl Rock in its investment in Amergin Asset Management;
  • Pacific General in its acquisition of a majority stake in Lenwich;
  • RedHill Biopharma in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • Taro in its acquisition of Alchemee, formerly The Proactiv Company, from Galderma; and
  • Thrivent in its acquisition of a majority stake in College Avenue.